The U.S. Supreme Court will announce its healthcare reform decision this month. Regardless of how the Court rules, this historic decision will have a significant impact on every American (young and old) and every employer and nonprofit organization, along with game-changing implications for government at all levels, insurers, hospitals, doctors, and businesses in the healthcare and life sciences sectors.
Join Venable LLP for a webinar/conference call on June 29 to discuss its effect on the clients we serve. Our team will include a former Democratic Congressman who, as a senior member of the House Energy and Commerce Committee, was involved in the drafting and passage of the law, two former top Federal agency officials, and a former Republican counsel to the House Energy and Commerce Committee.
In March 2010, President Obama signed into law the most sweeping social policy legislation passed by Congress in decades – the Patient Protection and Affordable Care Act (ACA). The constitutionality of certain portions of the law, however, has been challenged. As a result, there has been significant uncertainty as to whether the law will remain in place when the majority of the new healthcare reforms are scheduled to go into effect in 2014.
If the Court rules that the ACA is constitutional, Venable’s attorneys will help clients understand and comply with the new law. If any portion of the ACA is found unconstitutional, Venable’s team will help your organization consider the next steps.
Venable's webinar/conference call will consider the following:
- What the Supreme Court said and what remains of the new healthcare reform law;
- What impact the ruling may have on implementation of the law – implementation that occurred prior to the ruling and any implementation that may be required post-decision; and
- Who are the legislative and regulatory committees, agencies and leaders who will exercise jurisdiction over the next steps.
Ted L. Ramirez
Chair, Venable’s Healthcare Public Policy Group and co-chair of the Healthcare Transactions Practice
The Honorable Bart Stupak
Former U.S. Congressman and Senior Member of the House Energy and Commerce Committee
John F. Cooney
Former Deputy General Counsel for Litigation and Regulatory Affairs, Office of Management and Budget
William R. Nordwind
Former Counsel to the House Energy and Commerce Committee
Ralph S. Tyler
Former Maryland Insurance Commissioner, former Chief Counsel of the U.S. Food and Drug Administration (FDA)
Michael A. Gollin
Chair, Venable's Life Sciences Group
Thora A. Johnson
Partner, Venable's Employee Benefits and Executive Compensation Group
Christopher E. Condeluci
Former Tax Counsel to the Senate Finance Committee